The role of the immune system in modulating atherosclerosis has recently been well documented. Studies have revealed that cellular and humoral immunity plays crucial roles in atherogenic plaque formation. This includes macrophages, CD4+ T cells and dendritic cells as well as autoantigens such as oxidized low density lipoprotein (oxLDL), heat shock proteins and b2-glycoprotein I. Given these recent advances, various modifications of the immune system in experimental models have been proposed as therapeutic strategies, with the potential of inhibiting atherosclerosis progression. These modifications are switching the immune system (CD4+ T cells) from Th1 towards a Th2 anti-inflammatory cytokine secretion, and the induction of protective antibodies both of which may be induced by specific vaccination. Recent identification of specific immunoreactive antigenic epitopes on modified LDL, their successful implementation for immunization and the induction of atheroprotection, supports the idea that active vaccination may emerge as a novel immuno-modulating atheroprotective strategy.
Ehara S , Ueda M , Naruko Tet al.Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndrome . Circulation2001; 103: 1955-1960 .
2.
Matsura E , Kobayashi K , Koike Tet al.Atherogenic autoantigen: oxidized LDL complexes with b2-glycoprotein I . Immunobiology2003; 207: 17-22 .
3.
Perschinka H , Mayr M , Millonig Get al.Crossreactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis . Arterioscler Thromb Vasc Biol2003; 23: 1060-1065 .
4.
Palinski W , Ord VA , Plump ASet al.ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum . Arterioscler Thromb1994; 14: 605-616 .
5.
Toshima S , Hasegawa A , Kurabayashi Met al.Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease . Arterioscler Thromb Vasc Biol2000; 20: 2243-2247 .
6.
Hahn BH.Mechanisms of disease: antibodies to DNA . N Eng J Med1998; 338: 1359-1368 .
7.
Salonen JT , Yla-Hertualas , Yamamoto Ret al.Autoantibody against oxidized LDL and progression of carotid atherosclerosis . Lancet1992; 339: 883-887 .
8.
Lippy P.Inflammation in atherosclerosis . Nature2002; 420: 868-874 .
9.
Boes M.Role of natural and immune IgM antibodies in immune responses . Mol Immunol2000; 37: 1141-1149 .
10.
Stahl D , Sibrowski W.Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia . Curr Pharm Des2003; 9: 1871-1880 .
11.
Oppezzo P , Dighiero G.Autoantibodies, tolerance and autoimmunity . Pathol Biol2003; 51: 297-304 .
12.
Forger F , Matthias T , Oppermann M , Becker H , Helmke K.Clinical significance of anti-ds DNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis . Lupus2004; 13: 36-44 .
13.
Werwitzke S , Trick D , Kamino K , Matthias T , Kniesch K , Schlegelberger B.Treatment of murine SLE with IgM anti-dsDNA autoantibodies. In Conrad K , Bachman P , Chan EKLet al. eds. From animal models to human genetics; research on the induction and pathogenicity of autoantibodies. Berlin, Germany: PABST Science Publ , 2004: 107-109.
14.
Shaw PX , Horkko S , Chang M-Ket al.Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity . J Clin Invest2000; 105: 1731-1740 .
15.
Shoenfeld Y , Wu R , Dearing L , Matsuura E.Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective ? Circulation2004; 110: 2552-2558 .
16.
Palinski W , Horkko S , Miller Eet al.Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apoE2=2 mice. Demonstration of epitopes of oxLDL in human plasma . J Clin Invest1996; 98: 800-814 .
17.
Fukumoto M , Shoji T , Emoto Met al.Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population . Arterioscler Thromb Vasc Biol2000; 20: 703-707 .
18.
Monaco C , Crea F , Niccoli Get al.Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina, or peripheral vascular disease: pathophysiological implications . Eur Heart J2000; 22: 1572-1577 .
19.
Frostegard J , Kjellman B , Gidlund Met al.Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein . Atherosclerosis1996; 121: 93-103 .
20.
Mayr M , Metzler B , Keichl Set al.Endothelial ctotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis . Circulation1999; 99: 1560-1566 .
21.
Vink A , Poppen M , Schoneveld AHet al.Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual . Circulation2001; 103: 1613-1617 .
22.
George J , Harats D , Gilburd Bet al.Immunolocalization of beta2- glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression . Circulation1999; 99: 2227-2230 .
23.
Sherer Y , Tenenbaum A , Praprotnik Set al.Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta2-glycoprotein I, and oxidized LDL antibodies . Cardiology2001; 95: 20-24 .
24.
Ross R.Atherosclerosis - an inflammatory disease . N Eng J Med1999; 340: 115-126 .
25.
Zhou X , Caligiuri G , Hamsten A , Lefvert AK , Hansson GK.LDL immunization induces T-cell independent antibody formation and protection against atherosclerosis . Arterioscler Thromb Vasc Biol2001; 21: 108-114 .
26.
Iughetti L , Volta C , Maggi Eet al.Circulating antibodies recognizing oxidatively modified low-density lipoprotein in children . Pediatr Res1999; 45: 95-99 .
27.
Shoji T , Nishizawa Y , Fukumoto Met al.Inverse relationship between circulating oxidized low density lipoprotein (osLDL) and anti-oxLDL antibody levels in healthy subjects . Atherosclerosis2000; 148: 171-177 .
28.
Ameli S , Hultgardh-Nilsson A , Regnstrom Jet al.Effect of immunization with homologous LDL on early atherosclerosis in hypercholesterolemic rabbits . Arterioscler Thromb Vasc Biol1996; 16: 1074-1079 .
29.
Sherer Y , Shoenfeld Y.Immunomodulation for treatment and prevention of atherosclerosis . Autoimmun Rev2002; 1: 21-27 .
30.
Hansson GK.Vaccination against atherosclerosis . Circulation2002; 106: 1599-1601 .
31.
Moon BG , Takaki S , Miyake K , Takatsu K.The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production . J Immunol2004; 172: 6020-6029 .
32.
Binder CJ , Hartivigsen K , Chang MKet al.IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis . J Clin Invest2004; 114: 427-437 .
33.
Kopf M , Brombacher F , Hodkin PDet al.IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack of eosinophilia but have normal antibody and cytotoxic T cell responses . Immunity1996; 4: 15-24 .
34.
Fredrikson GN , Soderberg I , Lindholm Met al.Inhibition of atherosclerosis in ApoE-null mice by immunization with ApoB-100 peptide sequences . Arterioscler Thromb Vasc Biol2003; 23: 879-884 .
35.
Zhou X , Hansson G.Vaccination and atherosclerosis . Curr Atheroscler Rep2004; 6: 158-164 .
36.
Schipou A , Bengtsson J , Soderberg Iet al.Recombinant human antibodie against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis . Circulation2004; 110: 2047-2052 .
37.
Shah PK , Chyu K-Y , Fredrikson GN , Nilsson J.Vaccination for atherosclerosis: a novel therapeutic paradigm . Expert Rev Vaccines2004; 3: 1-6 .
38.
Nicolo D , Monestier M.Antiphospholipid antibodies and atherosclerosis . Clin Immunol2004; 112: 183-189 .
39.
George J , Yacov N , Breitbart Eet al.Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with b2-glycoprotein I . Cardiovascular Research2004; 62: 603-609 .
40.
Ohashi R , Mu H , Yao Q , Chen C.Atherosclerosis: immunopathogensis and immunotherapy . Med Sci Monit2004; 10: 255-260 .
41.
Mandal K , Jahangiri M , Xu Q.Autoimmunity to heat shock proteins in atherosclerosis . Autoimmun Rev2004; 3: 31-37 .
42.
Rittershaus CW , Miller DP , Thomas LJet al.Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis . Arterioscler Thromb Vasc Biol2000; 20: 2106-2112 .
43.
Davidson MH , Maki K , Umporowicz Det al.The safety and immunogenicity of a CETP vaccine in healthy adults . Artherosclerosis2003; 169: 113-120 .
